Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)
Bangladesh
· Delayed Price · Currency is BDT 829.00
+27.30 (3.41%)
At close: Jul 10, 2025
Ambee Pharmaceuticals Balance Sheet
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
Cash & Equivalents | 38.89 | 32.74 | 28.57 | 16.92 | 15.09 | 11.12 | Upgrade
|
Short-Term Investments | 100 | - | - | - | - | - | Upgrade
|
Cash & Short-Term Investments | 138.89 | 32.74 | 28.57 | 16.92 | 15.09 | 11.12 | Upgrade
|
Cash Growth | 305.61% | 14.61% | 68.81% | 12.12% | 35.79% | 99.64% | Upgrade
|
Receivables | 208.74 | 180.65 | 135.94 | 112.51 | 92.23 | 69.15 | Upgrade
|
Inventory | 228.4 | 221.91 | 197.25 | 178.89 | 128.89 | 160.25 | Upgrade
|
Prepaid Expenses | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade
|
Other Current Assets | 59.28 | 69.52 | 64.65 | 100.76 | 85.62 | 81.02 | Upgrade
|
Total Current Assets | 635.34 | 504.84 | 426.44 | 409.11 | 321.85 | 321.57 | Upgrade
|
Property, Plant & Equipment | 101.09 | 85.1 | 87.61 | 95.04 | 99.56 | 106.48 | Upgrade
|
Other Long-Term Assets | - | - | - | - | 0 | - | Upgrade
|
Total Assets | 736.42 | 589.94 | 514.05 | 504.15 | 421.42 | 428.05 | Upgrade
|
Accounts Payable | 4.26 | 5.59 | 4.98 | 6.55 | 7.22 | 10.06 | Upgrade
|
Accrued Expenses | 43.45 | 22.15 | 19.65 | 53.02 | 79.04 | 82.33 | Upgrade
|
Short-Term Debt | 623.54 | 476.56 | 392.35 | 343.8 | 235.67 | 222.7 | Upgrade
|
Current Portion of Leases | 0.57 | 0.6 | 0.13 | 1.07 | 2.75 | 2.7 | Upgrade
|
Current Income Taxes Payable | 27.51 | 25.16 | 31.54 | 36.34 | 38.44 | 37.39 | Upgrade
|
Current Unearned Revenue | - | 4.62 | - | - | - | - | Upgrade
|
Other Current Liabilities | 1.13 | 21.08 | 35.93 | 3.49 | 5 | 5.33 | Upgrade
|
Total Current Liabilities | 700.45 | 555.76 | 484.59 | 444.27 | 368.12 | 360.51 | Upgrade
|
Long-Term Leases | 0.2 | 0.24 | - | 0.01 | 1.42 | 2.33 | Upgrade
|
Long-Term Deferred Tax Liabilities | 3.55 | 4.51 | 6.12 | 7.17 | 7.04 | 7.36 | Upgrade
|
Other Long-Term Liabilities | 0 | - | 0 | - | - | - | Upgrade
|
Total Liabilities | 704.19 | 560.52 | 490.71 | 451.45 | 376.58 | 370.2 | Upgrade
|
Common Stock | 24 | 24 | 24 | 24 | 24 | 24 | Upgrade
|
Retained Earnings | 8.23 | 5.42 | -0.66 | 28.7 | 20.84 | 33.85 | Upgrade
|
Shareholders' Equity | 32.23 | 29.42 | 23.34 | 52.7 | 44.84 | 57.85 | Upgrade
|
Total Liabilities & Equity | 736.42 | 589.94 | 514.05 | 504.15 | 421.42 | 428.05 | Upgrade
|
Total Debt | 624.31 | 477.4 | 392.48 | 344.88 | 239.85 | 227.74 | Upgrade
|
Net Cash (Debt) | -485.42 | -444.66 | -363.91 | -327.96 | -224.75 | -216.62 | Upgrade
|
Net Cash Per Share | -202.26 | -185.28 | -151.63 | -136.65 | -93.65 | -90.26 | Upgrade
|
Filing Date Shares Outstanding | 2.4 | 2.4 | 2.4 | 2.4 | 2.4 | 2.4 | Upgrade
|
Total Common Shares Outstanding | 2.4 | 2.4 | 2.4 | 2.4 | 2.4 | 2.4 | Upgrade
|
Working Capital | -65.11 | -50.92 | -58.15 | -35.17 | -46.26 | -38.94 | Upgrade
|
Book Value Per Share | 13.43 | 12.26 | 9.73 | 21.96 | 18.68 | 24.10 | Upgrade
|
Tangible Book Value | 32.23 | 29.42 | 23.34 | 52.7 | 44.84 | 57.85 | Upgrade
|
Tangible Book Value Per Share | 13.43 | 12.26 | 9.73 | 21.96 | 18.68 | 24.10 | Upgrade
|
Land | 50.25 | 50.25 | 50.25 | 50.25 | 50.25 | 50.25 | Upgrade
|
Buildings | 29.95 | 29.95 | 29.95 | 29.95 | 29.08 | 29.08 | Upgrade
|
Machinery | 174.25 | 150.46 | 148.26 | 148.15 | 147.49 | 147.49 | Upgrade
|
Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.